Herbal Combination of Tithonia diversifolia, Moringa oleifera, and Curcuma longa as Antidiabetic Agent Against iNOS and COX-2 Proteins: An in silico Study
Article Sidebar
Main Article Content
Abstract
Diabetes mellitus (DM) is a condition characterized by chronic hyperglycemia, which is caused by a combination of insulin resistance and pancreatic β-cell dysfunction. These pathological processes are further exacerbated by oxidative stress and chronic inflammation. The enzymes inducible Nitric Oxide Synthase (iNOS) and Cyclooxygenase-2 (COX-2) have been reported to be major contributors to the inflammatory processes associated with DM. Therefore, this study aims to investigate the antidiabetic potential of a herbal combination of Tithonia diversifolia, Moringa oleifera, and Curcuma longa (TMC) using an in silico approach. The study also evaluated the inhibition of iNOS and COX-2 proteins by bioactive compounds in the treatment sample through molecular docking and dynamics simulations. Aqueous extracts of the TMC combination were analyzed using LC-HRMS to identify 17 bioactive compounds. After the screening procedure based on drug similarity and molecular properties, selected compounds were subjected to further analysis. The results showed that xanthurenic acid, piperanine, ferulic acid, and 57-dihydroxy-4-methylcoumarin were major compounds with significant binding affinities towards iNOS (-8.2, -8.8, -7.2, and -8.6 kcal/mol, respectively) and COX-2 (-7.9, -8.1, -7.2, and -8.0 kcal/mol, respectively). Molecular dynamics simulations further showed stable protein-ligand interactions, supporting their potential as alternative treatments for diabetes. In addition, the compounds exhibited relatively low toxicity, good membrane permeability, as well as effective antioxidant, anti-inflammatory, and antidiabetic bioactivities. These results showed the potential of xanthurenic acid, piperanine, ferulic acid, and 5,7-dihydroxy-4-methylcoumarin as effective inhibitors of both iNOS and COX-2, contributing to the treatment of DM.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
1. Eguchi N, Vaziri ND, Dafoe DC, Ichii H. The role of oxidative stress in pancreatic β cell dysfunction in diabetes. Int J Mol Sci. 2021;22(4):1-18.
2. Anavi S, Tirosh O. iNOS as a metabolic enzyme under stress conditions. Free Radic Biol Med. 2020;146:16-35.
3. Chan PC, Liao MT, Hsieh PS. Molecular Sciences The Dualistic Effect of COX-2-Mediated Signaling in Obesity and Insulin Resistance. 2019;20(13):3115.
4. Bartesaghi S, Radi R. Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration. Redox Biol. 2018;14:618-625.
5. Ranneh Y, Ali F, Akim AM, Hamid HA, Khazaai H, Fadel A. Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: a review. Appl Biol Chem. 2017;60(3):327-338.
6. Wang W, Zhong X, Guo J. Role of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review). Int J Mol Med. 2021;47(6).
7. Verma S, Gupta M, Popli H, Aggarwal G. Diabetes mellitus treatment using herbal drugs. Int J Phytomedicine. 2018;10(1):01.
8. Jamshidi-Kia F, Lorigooini Z, Amini-Khoei H. Medicinal plants: Past history and future perspective. J HerbMed Pharmacol. 2018;7(1):1-7.
9. Roglic G. WHO Global report on diabetes: A summary. Int J Noncommunicable Dis. 2016;1(1):3.
10. da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, Guariguata L, Seuring T, Zhang P, Cavan D, Makaroff LE. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract. 2016;117:48-54.
11. Zanzabil KZ, Hossain MS, Hasan MK. Diabetes Mellitus Management: An Extensive Review of 37 Medicinal Plants. Diabetology. 2023;4(2):186-234.
12. Mabou Tagne A, Marino F, Cosentino M. Tithonia diversifolia (Hemsl.) A. Gray as a medicinal plant: A comprehensive review of its ethnopharmacology, phytochemistry, pharmacotoxicology and clinical relevance. J Ethnopharmacol. 2018;220:94-116.
13. Chagas-Paula DA, Zhang T, da Costa FB, Edrada-Ebel RA. A Metabolomic Approach to Target Compounds from the Asteraceae Family for Dual COX and LOX Inhibition. Metabolites. 2015;5(3):404.
14. Vergara-Jimenez M, Almatrafi MM, Fernandez ML. Bioactive Components in Moringa Oleifera Leaves Protect against Chronic Disease. Antioxidants. 2017;6(4):91.
15. Mthiyane FT, Dludla P V., Ziqubu K, Mthembu SXH, Muvhulawa N, Hlengwa N, Nkambule BB, Mazibuko-Mbeje SE. A Review on the Antidiabetic Properties of Moringa oleifera Extracts: Focusing on Oxidative Stress and Inflammation as Main Therapeutic Targets. Front
Pharmacol. 2022;13:940572.
16. Memarzia A, Khazdair MR, Behrouz S, Gholamnezhad Z, Jafarnezhad M, Saadat S, Boskabady MH. Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review. Biofactors. 2021;47(3):311-350.
17. Adharini WI, Nilamsari RV, Lestari ND, Widodo N, Rifa’i M. Immunomodulatory Effects of Formulation of Channa micropeltes and Moringa oleifera through Anti-Inflammatory Cytokines Regulation in Type 1 Diabetic Mice. Pharm Sci. 2020;26(3):270-278.
18. Chagas CM, Moss S, Alisaraie L. Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five. Int J Pharm. 2018;549(1-2):133-149.
19. Pourzardosht N, Hashemi ZS, Mard-Soltani M, Jahangiri A, Rahbar MR, Zakeri A, Mirzajani E, Khalili S. Liothyronine could block the programmed death-ligand 1 (PDL1) activity: an e-Pharmacophore modeling and virtual screening study. J Recept Signal Transduct. 2022;42(1):34-
42.
20. Hardono H, Soetrisno S, Purwanto B, Wasita B, Nurwati I, Pamungkasari EP. In Silico Study of the Antidiabetic Effect of Ethyl Acetate Fraction of Banana Bract in Diabetic Rats. Trop J Nat Prod Res. 2024;8(11):9079-9085.
21. Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol. 2015;1263:243-250.
22. Ijoma IK, Okafor CE, Ajiwe VIE. Computational Studies of 5-methoxypsolaren as Potential Deoxyhemoglobin S Polymerization Inhibitor. Trop J Nat Prod Res. 2024;8(10):8835-8841.
23. Widyananda MH, Muflikhah L, Ulfa SM, Widodo N. Unveiling the antibreast cancer mechanism of Euphorbia hirta ethanol extract: computational and experimental study. J Biol Act Prod from Nat. 2024;14(3):359-382.
24. Poroikov V V., Filimonov DA, Gloriozova TA, Lagunin AA, Druzhilovskiy DS, Rudik AV, Stolbov LA, Dmitriev AV, Tarasova OA, Ivanov SM, Pogodin PV. Computer-aided prediction of biological activity spectra for organic compounds: the possibilities and limitations. Russ Chem Bull. 2019;68(12):2143-2154.
25. Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46:W257-W263.
26. Gheibi S, Ghasemi A. Insulin Secretion: The Nitric Oxide Controversy. EXCLI J. 2020;19:1227-1245.
27. Vona R, Gambardella L, Cittadini C, Straface E, Pietraforte D. Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases.
Oxid Med Cell Longev. 2019;2019(1):8267234.
28. Wang W, Zhong X, Guo J. Role of 2-series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non-alcoholic fatty liver disease (Review). Int J Mol Med. 2021;47(6):1-15.
29. Whitty A, Zhong M, Viarengo L, Beglov D, Hall DR, Vajda S. Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs. Drug Discov Today. 2016;21(5):712-717.
30. Liu H, Wei M, Yang X, Yin C, He X. Development of TLSER model and QSAR model for predicting partition coefficients of hydrophobic organic chemicals between low density polyethylene film and water. Sci Total Environ. 2017;574:1371-1378.
31. J. R. Yunta M. It Is Important to Compute Intramolecular Hydrogen Bonding in Drug Design? Am J Model Optim. 2017;5(1):24-57.
32. Daggupati T, Chitrala KN, Pamanji R, Yeguvapalli S. Molecular screening and analysis of novel therapeutic inhibitors against c-Jun N-terminal kinase. Med Chem Res. 2017;26(9):2112-2118.
33. Martínez L. Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLoS One. 2015;10(3).
34. Halder SK, Sultana I, Shuvo MN, Shil A, Himel MK, Hasan MA, Shawan MMAK. In Silico Identification and Analysis of Potentially Bioactive Antiviral Phytochemicals against SARS-CoV-2: A Molecular Docking and Dynamics Simulation Approach. Biomed Res Int. 2023;2023:5469258.
35. Kumar N, Sood D, Tomar R, Chandra R. Antimicrobial Peptide Designing and Optimization Employing Large-Scale Flexibility Analysis of Protein-Peptide Fragments. ACS Omega. 2019;4(25):21370-21380.
36. Filimonov DA, Lagunin AA, Gloriozova TA, Rudik AV, Druzhilovskii DS, Pogodin PV, Poroikov VV. Prediction of the biological activity spectra of organic compounds using the pass online web resource. Chem Heterocycl Compd. 2014;50(3):444-457.
37. Wargasetia TL, Ratnawati H, Widodo N, Widyananda MH. Antioxidant and Anti-inflammatory Activity of Sea Cucumber (Holothuria scabra) Active Compounds against KEAP1 and iNOS Protein. Bioinform Biol Insights. 2023;17.
38. Lomize AL, Hage JM, Schnitzer K, Golobokov K, LaFaive MB, Forsyth AC, Pogozheva ID. PerMM: A Web Tool and Database for Analysis of Passive Membrane Permeability and Translocation Pathways of Bioactive Molecules. J Chem Inf Model. 2019;59(7):3094-3099.
39. Liu JJ, Ching J, Wee HN, Liu S, Gurung RL, Lee J, M Y, Zheng H, Lee LS, Ang K, Shao YM, Kovalik JP, Subramaniam T, Sum CF, Sharma K, Kestenbaum BR, Lim SC. Plasma Tryptophan-Kynurenine Pathway Metabolites and Risk for Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes. Diabetes Care. 2023;46(12):2223-2231.
40. Lampiasi N, Montana G. The molecular events behind ferulic acid mediated modulation of IL-6 expression in LPS-activated Raw 264.7 cells. Immunobiology. 2016;221(3):486-493.
41. Chowdhury S, Ghosh S, Das AK, Sil PC. Ferulic acid protects hyperglycemia-induced kidney damage by regulating oxidative insult, inflammation and autophagy. Front Pharmacol. 2019;10(27):413222.
42. Derosa G, Maffioli P, Sahebkar A. Piperine and Its Role in Chronic Diseases. Adv Exp Med Biol. 2016;928:173-184.
43. Li C, Wang X, Qiao X, Fan L, Zhu H, Chen Y, He Y, Zhang Z. 5,7-Dihydroxy-4-methylcoumarin modulates the JNK/FoxO1 signaling pathway to attenuate cisplatin-induced ototoxicity by suppressing oxidative stress and apoptosis in vitro. Biochim Biophys Acta - Mol Cell Res. 2023;1870(4):119437.
44. Kang YS, Chung YC, Lee JN, Kim BS, Hyun CG. Anti-Inflammatory Effects of 6,7-Dihydroxy-4-Methylcoumarin on LPS-Stimulated Macrophage Phosphorylation in MAPK Signaling Pathways. Nat Prod Commun. 2021;16(5).